Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

National Institute of Health and Care Excellence (NICE) (UK) recommends Palforzia for treating peanut allergy in children – Aimmune/Nestle

Written by | 7 Feb 2022

NICE (UK)-Palforzia from Aimmune/Nestle is recommended, within its marketing authorisation, as an option for treating peanut allergy in children aged 4 to 17. It can be continued in… read more.

NFTs offer new method to control personal health information

Written by | 7 Feb 2022

NFTs, or nonfungible tokens, created using blockchain technology, first made a splash in the art world as a platform to buy and sell digital art backed by a… read more.

Disease flare and reactogenicity after covid vaccination in RMD patients

Written by | 7 Feb 2022

A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the… read more.

Updated results from pivotal HER2CLIMB trial evaluating Tukysa in patients with HER2-positive breast cancer – Seagen Inc

Written by | 6 Feb 2022

Seagen Inc. announced the presentation of new data from exploratory analyses from the pivotal HER2CLIMB trial showing that improvement in overall survival (OS) was maintained after an additional… read more.

Obesity may increase risk of some female reproductive disorders

Written by | 6 Feb 2022

Obesity is associated with an increased risk of developing female reproductive disorders, however, the roles and mechanisms of obesity in the cause(s) of reproductive conditions are unclear. A… read more.

European Commission approves Vaxneuvance (pneumococcal 15-valent conjugate vaccine) for individuals 18 years of age and older – Merck Inc

Written by | 5 Feb 2022

Merck Inc., announced that the European Commission (EC) has approved Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for active immunization for the prevention of invasive disease and pneumonia caused by… read more.

Repeated seasonal influenza vaccines also provide kids better protection against future flu pandemics, researchers find

Written by | 5 Feb 2022

Researchers at McMaster University have found that children who receive years of season-specific flu vaccines develop antibodies that also provide broader protection against new strains, including those capable… read more.

Epstein-Barr virus may be leading cause of multiple sclerosis

Written by | 4 Feb 2022

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr… read more.

Infant deaths from RSV are much higher than previously known

Written by | 4 Feb 2022

Nearly one in ten of all deceased infants under 6 months old were infected with Respiratory Syncytial Virus. A new study found that nearly one in ten of… read more.

Researchers discover how lactic acid weakens anti-tumor defenses

Written by | 3 Feb 2022

In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our… read more.

Researchers provide insight into how the brain multitasks while walking

Written by | 3 Feb 2022

New research turns the old idiom about not being able to walk and chew gum on its head. Scientists with the Del Monte Institute for Neuroscience at the… read more.

Lung cancer – urgent action required to get back on track

Written by | 3 Feb 2022

Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.